Log in or Sign up for Free to view tailored content for your specialty!
Prostate Cancer News
![1 in 6 Americans live at least 4 hours from proton beam therapy facility](https://cdn.statically.io/img/www.healio.com/~/media/slack-news/hemonc/misc/infographics/hot-infographics/2024/08_august/hot0724burus_graphic_01.jpg?w=400)
1 in 6 Americans live at least 4 hours from proton beam therapy facility
More than 16% of Americans live at least a 4-hour drive from the closest proton beam therapy facility, according to data published in JAMA Network Open.
Keto diet component may increase immunotherapy’s benefit in prostate cancer
![Keto diet component may increase immunotherapy’s benefit in prostate cancer](/~/media/slack-news/hemonc/misc/infographics/hot-infographics/2024/08_august/hot0524murphy_graphic_01.jpg?w=400)
The addition of a pre-ketone supplement to an immunotherapy regimen demonstrated efficacy for treating prostate cancer, according to a study led by researchers at University of Notre Dame.
Bone pain at diagnosis linked to poorer outcomes in advanced prostate cancer
![Bone pain at diagnosis linked to poorer outcomes in advanced prostate cancer](/~/media/slack-news/hemonc/misc/infographics/hot-infographics/2024/07_july/hot0724gebrael_graphic_01.jpg?w=400)
Men with bone pain at diagnosis of metastatic, hormone-resistant prostate cancer had shorter survival than men without bone pain, according to study results.
Log in or Sign up for Free to view tailored content for your specialty!
Machine Learning in Cancer Care with Shyam Natarajan, PhD
![Machine Learning in Cancer Care with Shyam Natarajan, PhD](/~/media/images/collections/hematology-oncology/resources/podcasts/oncology-overdrive/art/oncoverdrive_mug.jpg?w=80)
In this episode, host Shikha Jain, MD, speaks with Shyam Natarajan, PhD, about machine learning in cancer research and testing, using technological innovation to address disparities in health care trials and more.
Study reveals gaps in next-generation sequencing for patients with metastatic cancers
![Study reveals gaps in next-generation sequencing for patients with metastatic cancers](/~/media/slack-news/stock-images/hemonc/p/prostate_cancer_cells.jpeg?w=400)
Rates of next-generation sequencing have increased for individuals with metastatic prostate cancer or advanced urothelial carcinoma over the past several years, but more than half of these individuals still do not undergo testing.
High coffee intake may raise prostate cancer risk in tobacco smokers
![High coffee intake may raise prostate cancer risk in tobacco smokers](/~/media/slack-news/fm_im/misc/infographics/2024/07-july/pc0724weinstein_graphic_01_web.jpg?w=400)
CHICAGO — Drinking more than eight cups of coffee per day significantly increased the risk for prostate cancer among men who smoke tobacco, according to research presented at the annual NUTRITION meeting.
Long-term data support active surveillance as effective strategy for prostate cancer
![Long-term data support active surveillance as effective strategy for prostate cancer](/~/media/slack-news/hemonc/misc/infographics/hot-infographics/2024/07_july/hot0624newcomb_graphic_01_web.jpg?w=400)
Active surveillance for men with favorable-risk prostate cancer is an effective management strategy, according to data from a prospective cohort study published in JAMA.
‘Broader and more inclusive design’ needed for novel cancer trials
![‘Broader and more inclusive design’ needed for novel cancer trials](/~/media/slack-news/hemonc/misc/infographics/hot-infographics/2024/06_june/hot0624henegouwen_ig15.jpg?w=400)
Individuals with therapy-refractory cancer who received waivers to participate in a clinical trial for off-label targeted therapies achieved similar clinical benefits as those who took part in the study without an exception.
ASTRO names new chief executive officer
![ASTRO names new chief executive officer](/~/media/slack-news/hemonc/misc/infographics/hot-infographics/2024/06_june/hot0624kavadimilestone.jpg?w=400)
Vivek S. Kavadi, MD, MBA, FASTRO, has been named the new CEO for the American Society for Radiation Oncology.
Men with cancer history often do not receive recommended genetic testing
![Men with cancer history often do not receive recommended genetic testing](/~/media/slack-news/stock-images/fm_im/d/doctor_male_patient_adobe.jpg?w=400)
Only a small percentage of men recommended to undergo genetic testing due to personal or family history of cancer actually received it, according to findings published in Journal of the National Comprehensive Cancer Network.
-
Headline News
FDA approves epinephrine nasal spray for anaphylaxis
August 09, 20242 min read -
Headline News
Third person dies in multistate Listeria outbreak linked to deli meats
August 09, 20241 min read -
Headline News
Women may face greater allergy, respiratory risks from household cleaning product use
August 09, 20246 min read
-
Headline News
FDA approves epinephrine nasal spray for anaphylaxis
August 09, 20242 min read -
Headline News
Third person dies in multistate Listeria outbreak linked to deli meats
August 09, 20241 min read -
Headline News
Women may face greater allergy, respiratory risks from household cleaning product use
August 09, 20246 min read